+
Site Tour

EuroPCR 2023: Pivotal momentum for tricuspid valve intervention

Fabien Praz chairs this panel discussion on the pivotal momentum for tricuspid valve intervention. He is joined by Christian Besler, Phillipp Lurz, Paul Sorajja and Nina Wunderlich.

Related Videos

EuroPCR 2023: Vascular access

EuroPCR 2023: Defining the future

Navigating the Anatomy | Mitral focus

AV VALVES 2023: TR – Big Gaps

TriClip - AVVS 1 year 1 minute Tricuspid - Video

AV VALVES 2023: Morphology

AV VALVES 2023: Fast Forward 20 Years

AV VALVES 2023: Live Case – TEER

AV VALVES 2023: Staged, Concomitant

ESC 2023 Tutorial – TriClip™ | Dr. Sanchis

TRENDING TOPICS

Navigating the Anatomy | Tricuspid focus

Navigating the Anatomy | Tricuspid focus

F. Maisano, V. Delgado, P. Denti, M. Taramasso

Review the Trends | Tricuspid focus

Review the Trends | Tricuspid focus

M. Metra, G. Leurent, D. Tchetche, T. Nestelberger, D. Cohen, M. Adamo

Case Transmission | Tricuspid focus

Case Transmission | Tricuspid focus

F. Maisano, M. I. Koerber, H. Dreger, R. Bekeredjian, K. K. Yeo, T. Matsumoto

CONNEXT


TV
RELATED RESOURCES

EuroPCR 2023: Tricuspid valve

PCRLV 2022: Tricuspid valve intervention

AV VALVES 2023: TR – Atrial TR

AV VALVES 2023: Trending Topics – QoL

CONNEXT


HUB
RELATED RESOURCES

TriClip™ G4: Product overview

EuroEcho 2021: bRIGHT Gap Analysis

PCRLV 2022: bRIGHT 1 year

ESC 2021: HF & VHD Guidelines

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline